New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTVIVO, VIVO, VIVO, VRML, VRML, VRML, SYK, SYK, SYK, SNY, SNY, SNY, RHHBY, RHHBY, RHHBY, QGEN, QGEN, QGEN, PFE, PFE, PFE, MRK, MRK, MRK, LG, LG, LG, EXAS, EXAS, EXAS, COV, COV, COV, CYH, CYH, CYH, CPHD, CPHD, CPHD, BAYRY, BAYRY, BAYRY, ATHN, ATHN, ATHN, ABBV, ABBV, ABBV, A, A, AAmerican College of Obstetricians & Gynecologists to hold annual meeting
2104 Annual Clinical Meeting of ACOG is being held in Chicago on April 26-30.
News For A;ABBV;ATHN;BAYRY;CPHD;CYH;COV;EXAS;LG;MRK;PFE;QGEN;RHHBY;SNY;SYK;VRML;VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
June 23, 2015
14:17 EDTPFEGlycoMimetics to receive $20M payment from Pfizer
Subscribe for More Information
14:01 EDTPFEPfizer announces enrollment of first patient in RESET study
Subscribe for More Information
10:31 EDTBAYRYMonsanto says Bayer crop chemicals unit an option, Bloomberg reports
Subscribe for More Information
09:53 EDTPFEPfizer management to meet with FBN Securities
Meeting to be held in New York on June 25 hosted by FBN Securities.
07:25 EDTCOV, PFEPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
08:52 EDTPFEPortola, Bristol-Myers, and Pfizer announce results from Phase 3 ANNEXA study
Subscribe for More Information
07:53 EDTEXASExact Sciences estimates raised ahead of analyst Day at Canaccord
Canaccord raised its estimates on Exact Sciences ahead of June 26 Analyst Day. The firm cited the impact from the 160-person sales force addition from Ironwood Pharmaceuticals and pipeline opportunities beyond Cologuard for the increase. Canaccord raised its price target to $32 from $30 on Exact Sciences shares.
07:43 EDTSYKStryker management to meet with Deutsche Bank
Meeting to be held in Paris on June 22 hosted by Deutsche Bank.
07:01 EDTPFEPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
06:37 EDTCYHHealth insurers may change policies based on King v. Burwell ruling, NYT says
Subscribe for More Information
June 21, 2015
13:14 EDTMRKMerck shares could return 25%, Barron's says
Subscribe for More Information
June 19, 2015
10:09 EDTCYHFly Watch: Supreme Court may release key ACA decision soon
Subscribe for More Information
08:40 EDTEXASJefferies sees significant upside for Exact Sciences on positive USPSTF review
Subscribe for More Information
08:04 EDTCYHCommunity Health could see 50% upside in 18 months, says Susquehanna
Subscribe for More Information
07:37 EDTCYHSupreme Court decision on ACA suit due soon, says UBS
Subscribe for More Information
June 18, 2015
10:01 EDTATHNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:35 EDTPFEActive equity options trading on open
Subscribe for More Information
07:38 EDTCYHLeerink to hold a roundtable
Subscribe for More Information
07:36 EDTABBVReceptos remains an attractive takeover candidate, says Leerink
Subscribe for More Information
05:24 EDTQGENQIAGEN, Hitachi High-Technologies enter into long-term strategic collaboration
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use